Genetic testing resulted in three VUS genetic variants including RSPH4A, DNAAF3, and DNAH11. Although none of these genetic VUS had been associated with PCD pathogenic phenotype; the medical history, clinical findings, electron microscopy, and the severity of her pulmonary disease evidenced by pulmonary function test and imaging, highly suggest PCD. This evidence concerns the gene DNAAF3 and lung disorder.